Bioray Pharmaceutical Co., Ltd.

This early-stage study tested a new drug called BRY805 in adults with advanced solid tumors that hadn't responded to standard treatments. The main goal was to check the drug's safety, find the right dose, and see if it showed any signs of fighting cancer. The trial was terminated…

This was an early-stage study to test the safety and find the right dose of a new drug called BR105 in adults with advanced cancers that have not responded to standard treatments. Researchers gave the drug by IV infusion and closely monitored patients for side effects over 21 day…

This early-stage study tested a new drug called BR108 injection in adults with advanced blood cancers that had returned or stopped responding to other treatments. The main goal was to check the safety, side effects, and how the body processes the drug. The study was terminated af…

This early-stage study aimed to see if a new drug called HS632 acts similarly in the body to an existing allergy medication, omalizumab (Xolair®). It involved giving a single injection to healthy male volunteers to compare how the drugs are processed and their safety. The trial w…